Idarucizumab - CISMeF

Preferred Label : Idarucizumab;

NCIt definition : A humanized monoclonal antibody fragment directed against the thrombin-binding site of dabigatran, that may be used as a specific reversal agent for dabigatran. Upon intravenous administration, idarucizumab binds to dabigatran and its acylglucuronide metabolites with a higher affinity than the binding affinity of dabigatran to thrombin, thereby neutralizing the anticoagulant effect of dabigatran.;

UNII : 97RWB5S1U6;

CAS number : 1362509-93-0;

Drug name : Praxbind;

Molecule name : BI 655075; BI-655075;

Codes from synonyms : 266;

Details

Origin ID

C128646;

UMLS CUI

C3885063;

Currated CISMeF NLP mapping
- Idarucizumab [ICD-11 Extension code]
- Idarucizumab [SMS substance]
- Idarucizumab [Anticorps monoclonal]
- Idarucizumab (substance) [SNOMED CT concept]
- idarucizumab [MeSH Supplementary Concept]
- idarucizumab [MeSH concept]
See also inter- (CISMeF)
- Product containing idarucizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Idarucizumab (substance) [SNOMED CT concept]
- Product containing idarucizumab (medicinal product) [SNOMED CT concept]
- idarucizumab [ATC Code]
- idarucizumab [MeSH Supplementary Concept]
- idarucizumab [MeSH concept]
Validated automatic mappings to BTNT
- idarucizumab [ATC Code]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients